ALNYLAM PHARMACEUTICALS INC. earnings per share and revenue

DUL earnings per share for the last quarter are -0.48 EUR whereas the estimation was -1.03 EUR which accounts for 53.41% surprise. Company revenue for the same period amounts to 458.14 M EUR despite the estimated figure of 396.67 M EUR. Estimated earnings per share for the next quarter are -0.98 EUR, and revenue is expected to reach 415.28 M EUR. Also watch annual changes over time to get a bigger picture of DUL earnings per share and revenue dynamics.